Identification of selective agonists and antagonists to G protein-activated inwardly rectifying potassium channels: Candidate medicines for drug dependence and pain

Current Neuropharmacology

Volumn 9, Issue 1, 2011, Pages 113-117

  Nishizawa, D ^a   Gajya, N ^b   Ikeda, K ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b Pfizer Japan Inc   (Japan)

Author keywords

Agonist; Antagonist; G protein activated inwardly rectifying k+ (GIRK; Kir channel; Kir3) channels; Pfizer compounds; Xenopus oocyte

Indexed keywords

FLUOXETINE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL AGONIST; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL ANTAGONIST; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG IDENTIFICATION; DRUG INHIBITION; DRUG SCREENING; ELECTROPHYSIOLOGY; MOLECULAR WEIGHT; NONHUMAN; OOCYTE; PAIN; PROTEIN EXPRESSION; VOLTAGE CLAMP; XENOPUS LAEVIS;

EID: 79953038228     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015911795017227     Document Type: Article

References (22)

1. Jelacic, T.M.; Kennedy, M.E.; Wickman, K.; Clapham, D.E. Functional and biochemical evidence for G-protein-gated inwardly rectifying K+ (GIRK) channels composed of GIRK2 and GIRK3. J. Biol. Chem., 2000, 275, 36211-36216.
2. Kobayashi, T.; Ikeda, K.; Ichikawa, T.; Abe, S.; Togashi, S.; Kumanishi, T. Molecular cloning of a mouse G-protein-activated K+ channel (mGIRK1) and distinct distributions of three GIRK (GIRK1, 2 and 3) mRNAs in mouse brain. Biochem. Biophys. Res. Commun., 1995, 208, 1166-1173.
3. Wickman, K.; Karschin, C.; Karschin, A.; Picciotto, M.R.; Clapham, D.E. Brain localization and behavioral impact of the Gprotein-gated K+ channel subunit GIRK4. J. Neurosci., 2000, 20, 5608-5615.
4. Corey, S.; Clapham D.E. Identification of native atrial G-proteinregulated inwardly rectifying + (GIRK4) channel homomultimers. J. Biol. Chem., 1998, 273, 27499-27504.
5. Wickman, K.; Nemec, J.; Gendler, S.J.; Clapham, D.E. Abnormal heart rate regulation in GIRK4 knockout mice. Neuron, 1998, 20, 103-114.
6. Ikeda, K.; Kobayashi, T.; Kumanishi, T.; Yano, R.; Sora, I.; Niki, H. Molecular mechanisms of analgesia induced by opioids and ethanol: is the GIRK channel one of the keys? Neurosci. Res., 2002, 44, 121-131.
7. Blednov, Y.A.; Stoffel, M.; Alva, H.; Harris, R.A. A pervasive mechanism for analgesia: activation of GIRK2 channels. Proc. Natl. Acad. Sci. USA, 2003, 100, 277-282.
8. Marker, C.L.; Cintora, S.C.; Roman, M.I.; Stoffel, M.; Wickman, K. Hyperalgesia and blunted morphine analgesia in G protein-gated potassium channel subunit knockout mice. Neuroreport, 2002, 13, 2509-2513.
9. Marker, C.L.; Lujan, R.; Loh, H.H.; Wickman, K. Spinal Gprotein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of μ- and δ- but not κ-opioids. J. Neurosci., 2005, 25, 3551-3559.
10. Marker, C.L.; Stoffel, M.; Wickman, K. Spinal G-protein-gated K+ channels formed by GIRK1 and GIRK2 subunits modulate thermal nociception and contribute to morphine analgesia. J. Neurosci., 2004, 24, 2806-2812.
11. Mitrovic, I.; Margeta-Mitrovic, M.; Bader, S.; Stoffel, M.; Jan, L.Y.; Basbaum, A.I. Contribution of GIRK2-mediated postsynaptic signaling to opiate and α2-adrenergic analgesia and analgesic sex differences. Proc. Natl. Acad. Sci. USA, 2003, 100, 271-276.
12. Morgan, A.D.; Carroll, M.E.; Loth, A.K.; Stoffel, M.; Wickman, K. Decreased cocaine self-administration in Kir3 potassium channel subunit knockout mice. Neuropsychopharmacology, 2003, 28, 932-938.
13. Kobayashi, T.; Ikeda, K.; Kumanishi, T. Effects of clozapine on the δ- and κ -opioid receptors and the G-protein-activated K+ (GIRK) channel expressed in Xenopus oocytes. Br. J. Pharmacol., 1998, 123, 421-426.
14. Kobayashi, T.; Ikeda, K.; Kumanishi, T. Inhibition by various antipsychotic drugs of the G-protein-activated inwardly rectifying K+ (GIRK) channels expressed in Xenopus oocytes. Br. J. Pharmacol., 2000, 129, 1716-1722.
15. Kobayashi, T.; Washiyama, K.; Ikeda, K. Inhibition of G proteinactivated inwardly rectifying K+ channels by various antidepressant drugs. Neuropsychopharmacology, 2004, 29, 1841-1851.
16. Kobayashi, T.; Washiyama, K.; Ikeda, K. Modulators of G proteinactivated inwardly rectifying K+ channels: potentially therapeutic agents for addictive drug users. Ann. NY Acad. Sci., 2004, 1025, 590-594.
17. Kobayashi, T.; Washiyama, K.; Ikeda, K. Inhibition of G proteinactivated inwardly rectifying K+ channels by the antidepressant paroxetine. J. Pharmacol. Sci., 2006, 102, 278-287.
18. Kobayashi, T.; Ikeda, K.; Kojima, H.; Niki, H.; Yano, R.; Yoshioka, T.; Kumanishi, T. Ethanol opens G-protein-activated inwardly rectifying K+ channels. Nat. Neurosci., 1999, 2, 1091-1097.
19. Lewohl, J.M.; Wilson, W.R.; Mayfield, R.D.; Brozowski, S.J.; Morrisett, R.A.; Harris, R.A. G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action. Nat. Neurosci., 1999, 2, 1084-1090.
20. Weigl, L.G.; Schreibmayer, W. G protein-gated inwardly rectifying potassium channels are targets for volatile anesthetics. Mol. Pharmacol., 2001, 60, 282-289.
21. keda, K.; Yoshii, M.; Sora, I.; Kobayashi, T. Opioid receptor coupling to GIRK channels. In vitro studies using a Xenopus oocyte expression system and in vivo studies on weaver mutant mice. Methods. Mol. Med., 2003, 84, 53-64.
22. Kobayashi, T.; Washiyama, K.; Ikeda, K. Inhibition of G proteinactivated inwardly rectifying K+ channels by fluoxetine (Prozac). Br. J. Pharmacol., 2003, 138, 1119-1128.